Selexis to Meet with Companies Interested in Cell Line Development and Lead Identification for Therapeutic Drug Development and Manufacturing
Geneva, Switzerland (PRWEB) April 10, 2013 – Selexis SA, a global life sciences company for drug discovery, cell line development and scale-up to manufacturing of therapeutic proteins, announced today today representatives from the Company will be participating in the BIO International Convention’s One-on-One Partnering Meetings being held April 22 – 25, 2013 at McCormick Place in Chicago, IL.
Selexis has partnerships and commercial deals with leading biotechnology and pharmaceutical companies worldwide. Selexis’ SUREtechnology Platform™ allows for faster and more reliable cell line development with higher expression levels which can be applied to a wide range of areas such as bio-manufacturing, drug discovery, diagnostics, and therapeutics.
Representatives will be available to discuss Selexis’ capabilities. Companies or individuals attending BIO 2013 can schedule meetings with Selexis by visiting (registration required): http://convention.bio.org/partner/
Selexis Business Forum Partnering Schedule:
Monday, April 22 Business Forum - 08:00 AM – 05:00 PM
Tuesday, April 23 Business Forum - 08:00 AM – 05:00 PM
Wednesday, April 24 Business Forum - 08:00 AM – 05:00 PM
Thursday, April 25 Business Forum - 08:00 AM – 12:00 PM
For companies or individuals not participating in partnering meetings, Selexis will be exhibiting in booth number #4158 located in Hall C
Selexis Exhibit Hall Schedule and Partnering:
Monday, April 22 Hall C - 12:00 PM – 05:00 PM
Tuesday, April 23 Hall C - 10:00 AM – 05:00 PM
Wednesday, April 24 Hall C - 10:00 AM – 05:00 PM
Thursday, April 25 Hall C - 10:00 AM – 12:00 PM
